3.6 In conclusion
Table 3.5 summarises the current and forthcoming antiviral EPI vaccines in Ethiopia.
| Vaccine | Protects against | Doses/when | Route |
|---|---|---|---|
| HepB | Hepatitis B | Three: at 6, 10 and 14 weeks, in the pentavalent vaccine | Intramuscular, upper outer left thigh |
| OPV | Poliomyelitis | Four: at birth, then at 6, 10 and 14 weeks (additional campaign doses may be given) | Oral (drops into the mouth) |
| Measles | Measles | One: at 9 months, or as soon as possible thereafter (plus one additional campaign dose) | Subcutaneous, outer upper arm |
| Rotavirus | Rotavirus diarrhoea | Two: at 6 and 10 weeks (but first dose no later than 12 weeks, second dose no later than 24 weeks, with an interval of at least 4 weeks between doses) | Oral (drops into the mouth) |
Back to previous pagePrevious
3.5 Yellow fever vaccine
